A series of novel 2-chloro-3-(1H-benzo[d]imidazol-2-yl)quinoline derivatives were designed and synthesized as antitumor agents under the combination principle. The antitumor activity and mechanisms were then evaluated.
一系列新颖的2-
氯-3-(1H-苯并[d]
咪唑-2-基)
喹啉衍
生物被设计和合成为
抗肿瘤药物,根据联合原则。然后评估了这些抗肿瘤活性和机制。